These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 7206329)
21. [Serum levels and urinary excretion of 25-hydroxyvitamin-D in renal failure (author's transl)]. Ohhara K Nihon Jinzo Gakkai Shi; 1978 Mar; 20(3):281-9. PubMed ID: 671853 [No Abstract] [Full Text] [Related]
22. [The experimental and clinical studies of oxystarch in chronic renal failure (author's transl)]. Inoshita K Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):315-30. PubMed ID: 7382171 [No Abstract] [Full Text] [Related]
23. [Vitamin D and renal failure (author's transl)]. Fuss M; Corvilain J Rev Med Brux; 1981 Apr; 2(4):441-5. PubMed ID: 7291796 [No Abstract] [Full Text] [Related]
24. [Calcium and phosphorus metabolism in patients on chronic intermittent haemodialysis with different calcium concentrations in the dialysate (author's transl)]. Kovarik J; Graf H; Stummvoll HK; Wolf A; Pinggera W Wien Klin Wochenschr; 1979 Nov; 91(22):765-8. PubMed ID: 516748 [TBL] [Abstract][Full Text] [Related]
27. [Circulatory and metabolic changes during submaximum exertion in patients with chronic renal failure treated by regular dialysis (author's transl)]. Tomásek R; Lisý Z; Válek A; Pick P; Straková M Sb Lek; 1975 Sep; 77(9):278-88. PubMed ID: 1179147 [No Abstract] [Full Text] [Related]
28. [Use of drugs in patients with renal failure (author's transl)]. Díes F Rev Invest Clin; 1979; 31(3):199-209. PubMed ID: 523855 [No Abstract] [Full Text] [Related]
29. [Critical evaluation of some laboratory parameters of derangements in calcium, magnesium and phosphorus metabolism in patients treated by chronic intermittent haemodialysis (author's transl)]. Revúsová V; Zvara V; Gratzlová J; Reznícek J; Borosová E Bratisl Lek Listy; 1976 Apr; 65(4):378-83. PubMed ID: 963558 [No Abstract] [Full Text] [Related]
30. [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency]. Schulz W; Spiegel P; Gessler U; Delling G Verh Dtsch Ges Inn Med; 1978; (84):1297-301. PubMed ID: 741953 [No Abstract] [Full Text] [Related]
31. [Calcium metabolism disorders and bone changes in chronic renal insufficiency; alternatives of examination (author's transl)]. Sotorník I; Dráb K; Kocián J; Povýsil C Cas Lek Cesk; 1977 Nov; 116(47):1456-60. PubMed ID: 597831 [No Abstract] [Full Text] [Related]
32. A pilot study of metabolic effects of intravenously given alpha-calcidol in patients with chronic renal failure. Lind L; Lithell H; Wengle B; Wrege U; Ljunghall S Scand J Urol Nephrol; 1988; 22(3):219-22. PubMed ID: 3187441 [TBL] [Abstract][Full Text] [Related]
33. [Hyperphosphoremia states in hemodialysed patients with chronic renal insufficiency]. Duchatelle P; Lelievre G; Tacquet A Lille Med; 1973 Feb; 18(2):116-24. PubMed ID: 4732957 [No Abstract] [Full Text] [Related]
34. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results]. Cremer W; Graben N; Merguet P Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841 [No Abstract] [Full Text] [Related]
35. Calcium absorption in renal failure: its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables. Recker RR; Saville PD J Lab Clin Med; 1971 Sep; 78(3):380-8. PubMed ID: 5092859 [No Abstract] [Full Text] [Related]
36. Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. Rix M; Eskildsen P; Olgaard K Nephrol Dial Transplant; 2004 Apr; 19(4):870-6. PubMed ID: 15031343 [TBL] [Abstract][Full Text] [Related]